The use of granulocyte colony-stimulating factor (G-CSF), which stimulates neutrophil recovery after chemotherapy and thus alleviates drug-induced neutropenia, may allow the delivery of chemotherapy as scheduled in patients with breast cancer (de Graaf et al, 1996). Here, CSF3 is linked to breast cancer.